Join to View Full Profile
Massachusetts General Hospital55 Fruit StreetBoston, MA 02114
Phone+1 617-726-2862
Dr. Bendapudi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2015- Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Blood Banking/Transfusion Medicine, 2011 - 2012
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
Stanford University School of MedicineClass of 2008
Certifications & Licensure
MA State Medical License 2010 - 2027
FL State Medical License 2021 - 2023
American Board of Internal Medicine Hematology
American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- Targeting factor XI for venous thromboembolism prevention: a tale of 2 antibodies.Steven P Grover, Pavan K Bendapudi
Journal of Thrombosis and Haemostasis. 2026-03-07 - Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.Elena Martinelli, Juntao Ke, Atlas Khan, Janewit Wongboonsin, David R Vanderwall
JAMA Network Open. 2026-03-02 - Case 6-2026: A 91-Year-Old Man with Shortness of Breath, Weight Loss, and Eosinophilia.Pavan K Bendapudi, Maximiliano Klug, Sharl S Azar, Mandakolathur R Murali, Ayman Al Jurdi
The New England Journal of Medicine. 2026-02-19
Press Mentions
Newer Blood Thinners Surpass Warfarin for Treating Seniors with Afib and Prior StrokeApril 14th, 2022- Clinicians Report Success with First Test of Drug in a Patient with Life-Threatening Blood Clotting DisorderMay 17th, 2024
- Medical Professionals See Positive Results in Initial Trial of Medication for Severe Blood Clotting DisorderMay 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
